1-7 of 7
Neville Lee
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

DNMT3A mutations are unlikely to affect interferon alfa treatment outcomes in patients with polycythemia vera

Ghaith Abu-Zeinah, Katie Erdos, Neville Lee, Yara Ganom, Christoph Klade, Kurt Krejcy, Heinz Gisslinger, Richard T. Silver, Joseph Michael Scandura
Journal: Blood
Blood blood.2024027528.
https://doi.org/10.1182/blood.2024027528
Published: 2025
Includes: Supplemental data
Journal Articles

DNMT3A Mutations Do Not Affect Treatment Response or Outcomes for Patients with Polycythemia Vera Treated with Interferon Alpha

Ghaith Abu-Zeinah, Katie Erdos, Neville Lee, Jr., Richard T. Silver, Joseph M. Scandura
Journal: Blood
Blood (2024) 144 (Supplement 1): 3190.
https://doi.org/10.1182/blood-2024-210703
Published: 2024
Journal Articles

Validating the MPN Personalized Risk Calculator in 475 Patients with Polycythemia Vera

Katie Erdos, Neville Lee, Jr., Yushu Shi, Ghaith Abu-Zeinah, Joseph M. Scandura
Journal: Blood
Blood (2024) 144 (Supplement 1): 4558.
https://doi.org/10.1182/blood-2024-210632
Published: 2024
Journal Articles

Ropeginterferon Alfa-2b (ROPEG) and Peginterferon Alfa-2a (PEG) at Low Dose with Response-Based Titration (LDRT) Have Comparable Efficacy and Tolerability in Polycythemia Vera (PV)

Neville Lee, Jr., Katie Erdos, Aqib Abdul Rahman, Richard T. Silver, Joseph M. Scandura, Ghaith Abu-Zeinah
Journal: Blood
Blood (2024) 144 (Supplement 1): 4568.
https://doi.org/10.1182/blood-2024-211143
Published: 2024
Journal Articles

Importance of Diagnosing Polycythemia Vera (PV) Patients (pts) Whose Hematocrit (HCT)/Hemoglobin (HGB) Are Less Than the Who 2022 Stipulated Criteria

Neville Lee, Jr., Katie Erdos, Joseph M. Scandura, Ghaith Abu-Zeinah, Richard T. Silver
Journal: Blood
Blood (2023) 142 (Supplement 1): 6434.
https://doi.org/10.1182/blood-2023-189643
Published: 2023
Journal Articles

Low Thrombosis Risk CALR Mutations Confer Higher Risk of Essential Thrombocythemia Progression

Katie Erdos, Neville Lee, Jr., Ahamed Lebbe, Imane Bouhali, Mohammed Khalid, Ghaith Abu-Zeinah, Richard T. Silver, Joseph M. Scandura
Journal: Blood
Blood (2023) 142 (Supplement 1): 1819.
https://doi.org/10.1182/blood-2023-188952
Published: 2023
Journal Articles

Marrow Hypercellularity Does Not Exclude the Diagnosis of Essential Thrombocythemia (ET)

Katie Erdos, Madhu M Ouseph, Julia Geyer, Neville Lee, Jr., Ghaith Abu-Zeinah, Joseph M. Scandura, Richard T. Silver
Journal: Blood
Blood (2023) 142 (Supplement 1): 3198.
https://doi.org/10.1182/blood-2023-187769
Published: 2023